Karsten Stahnke

895 citations

23 papers · 635 indexed · h-index 15

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics
- Hemoglobinopathies and Related Disorders

Papers in

Hematology 9
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 3
Public Health, Environmental and Occupational Health 9
- Acute Lymphoblastic Leukemia research 9

Co-authors: Klaus‐Michael Debatin Simone Fulda E. Kohne Joachim Boos Gudrun Strauß Claudia Friesen Andrea Mohr Ursula Creutzig
Journals: Blood (3 papers)Leukemia (2 papers)Annals of Hematology (2 papers)Clinical Cancer Research (1 paper)British Journal of Haematology (1 paper)
Partner nations: Germany United States Switzerland

In The Last Decade

Karsten Stahnke

23 papers receiving 620 citations

Peers

Countries citing papers authored by Karsten Stahnke

Since Specialization

Citations

This map shows the geographic impact of Karsten Stahnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Stahnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Stahnke more than expected).

Fields of papers citing papers by Karsten Stahnke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Stahnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Stahnke. The network helps show where Karsten Stahnke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karsten Stahnke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karsten Stahnke Line = papers co-authored together Karsten Stahnke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Important Role of Caspase-8 for Chemosensitivity of ALL Cells Clinical Cancer Research ·Harald Ehrhardt, Franziska Wachter, Martina Maurer, Karsten Stahnke, Irmela Jeremias	2011	21
2	Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways Cancer Cell ·Lüder Hinrich Meyer, Yonglong Chen, Manon Queudeville, Johann M. Kraus, Marco Giordan, U. Undetermined, Andrea Zangrando, Elena Vendramini, Anja Möricke, Martin Zimmermann, André Schrauder, Georgia Lahr, Karlheinz Holzmann, Martin Schrappe, Giuseppe Basso, Karsten Stahnke, Hans A. Kestler, Geertruy te Kronnie, Klaus‐Michael Debatin	2011	60
3	4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG Cell Death and Differentiation ·Gudrun Strauß, Mike‐Andrew Westhoff, Pamela Fischer‐Posovszky, Simone Fulda, 燕红陈, Yonglong Chen, Karsten Stahnke, Nicola Vahsen, Guido Kroemer, Klaus‐Michael Debatin	2007	38
4	Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML Blood ·Lüder Hinrich Meyer, Manon Queudeville, Yonglong Chen, Ursula Creutzig, Dirk Reinhardt, Leonid Karawajew, Wolfgang Ludwig, Karsten Stahnke, Klaus‐Michael Debatin	2007	8
5	CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes Cancer Immunology Immunotherapy ·Irmela Jeremias, Karsten Stahnke, Klaus‐Michael Debatin	2005	11
6	Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis Oncogene ·Andrea Mohr, Ralf M. Zwacka, 中山耕造, 周鸿锦, Hubert Schrezenmeier, Konstanze Döhner, Christian Beltinger, Markus Wiesneth, Klaus‐Michael Debatin, Karsten Stahnke	2005	42
7	Identification of deficient mitochondrial signaling in apoptosis resistant leukemia cells by flow cytometric analysis of intracellular cytochrome c, caspase-3 and apoptosis APOPTOSIS ·Karsten Stahnke, Andrea Mohr, 由文瀧ノ上, Clarisse Jacquin-Becker and, Leonid Karawajew, Klaus‐Michael Debatin	2004	29
8	Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells Leukemia ·Karsten Stahnke, Yonglong Chen, Andrea Mohr, Mani Baba Ali, Klaus‐Michael Debatin	2003	33
9	Apoptosis in hematological disorders Seminars in Cancer Biology ·Klaus‐Michael Debatin, Karsten Stahnke, Simone Fulda	2003	28
10	Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL‐BFM 95 reinduction treatment British Journal of Haematology ·Hans‐Joachim Müller, Rita Beier, Lutz Löning, Renate Blütters‐Sawatzki, W Dörffel, (unknown), Stefan Müller‐Weihrich, Akbal Mohamed Amine, Franziska Scherer, Karsten Stahnke, Martin Schrappe, co-promotor Dewi Irawaty, Yusei Fujita, Joachim Boos	2001	79
11	Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy Blood ·Karsten Stahnke, Simone Fulda, Claudia Friesen, Gudrun Strauß, Klaus‐Michael Debatin	2001	73
12	Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter β-thalassemia study Annals of Hematology ·Holger Cario, Karsten Stahnke, Silvia Sander, E. Kohne	2000	25
13	β-Thalassämie in Deutschland Klinische Pädiatrie ·Holger Cario, Karsten Stahnke, E. Kohne	1999	7
14	Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia Leukemia ·Karsten Stahnke, Joachim Boos, Christine Bender‐Götze, J. Ritter, M Zimmermann, Ursula Creutzig	1998	55
15	Prognose von Kindern mit AML nach dem ersten Rezidiv Klinische Pädiatrie ·Ursula Creutzig, J. Ritter, Joachim Boos, Martin Zimmermann, Christine Bender‐Götze, Karsten Stahnke	1998	2
16	CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells. PubMed ·Karsten Stahnke, Benjamin Faudemer, E. Kohne, Klaus‐Michael Debatin	1998	47
17	Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction Biochemical Society Transactions ·Klaus‐Michael Debatin, Christian Beltinger, Thomas Böhler, Jörg Fellenberg, Claudia Friesen, Simone Fulda, Ingrid Herr, (unknown), Y Ranjith, Hauke Sieverts, Karsten Stahnke	1997	22
18	Therapy of childhood acute myelogenous leukemias Annals of Hematology ·Josef Vormoor, Joachim Boos, Karsten Stahnke, H. Jürgens, J. Ritter, Ursula Creutzig	1996	15
19	Multizentrische deutsche Thalassämie-Studie Klinische Pädiatrie ·E. Kohne, Karsten Stahnke, Andreas E. Kulozik, E. Kleihauer	1992	2
20	Rezidivbehandlung bei akuter myeloischer Leukämie im Kindesalter Klinische Pädiatrie ·Karsten Stahnke, J. Ritter, Fulvio E. Jaramillo, Jörn‐Dirk Beck, H. Kabisch, F. Lampert, U. Creutzig	1992	6

About Karsten Stahnke

Karsten Stahnke is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Genetics and Immunology, having authored 23 papers that have together received 635 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Acute Myeloid Leukemia Research (6 papers), RNA Interference and Gene Delivery (4 papers), Neutropenia and Cancer Infections (3 papers), Phagocytosis and Immune Regulation (3 papers), Hemoglobinopathies and Related Disorders (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Hematology (197 citations), Genetics (76 citations), Public Health, Environmental and Occupational Health (191 citations), Oncology (150 citations) and Molecular Biology (327 citations). Karsten Stahnke has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Klaus‐Michael Debatin, Simone Fulda, E. Kohne, Joachim Boos, Gudrun Strauß, Claudia Friesen, Andrea Mohr, Ursula Creutzig, Martin Schrappe and Christine Bender‐Götze. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, Clinical Cancer Research and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact